---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-26-000037"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2026-06-04T20:05:16+00:00"
generated_at: "2026-06-04T20:07:40.706866+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Evolent Health shareholders elect 10 directors, approve incentive plan amendment at June 4 meeting

## Summary
- All 10 director nominees elected with majority support; vote tallies range from 60.0M to 65.9M 'for' votes.
- Advisory say-on-pay resolution approved 58.4M for vs 7.9M against (88% of votes cast).
- Amendment to 2015 Omnibus Incentive Compensation Plan passed with 47.5M for, 18.7M against (71.8% of votes cast).
- Ratification of Deloitte & Touche as auditor for FY2026 passed with 82.0M for, 0.1M against.

## SEC filing metadata
- accession: 0001628908-26-000037
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2026-06-04T20:05:16+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/evh-20260604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-26-000037
- JSON: https://secwatch.observer/filing/0001628908-26-000037.json
- Plain text: https://secwatch.observer/filing/0001628908-26-000037.txt

## Key facts
- Shareholder Votes
  Evolent Health, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 as set forth below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm
- Shareholder Votes
  Evolent Health, Inc. shareholders approved Election of ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the 2027 annual meeting at the 2026-06-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: The Company’s stockholders elected ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, as set forth below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm
- Shareholder Votes
  Evolent Health, Inc. shareholders approved Advisory approval of compensation of named executive officers for 2025 at the 2026-06-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: The Company’s stockholders approved the compensation of our named executive officers for 2025 on an advisory basis, as set forth below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm
- Shareholder Votes
  Evolent Health, Inc. shareholders approved Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan at the 2026-06-04 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: The Company’s stockholders approved the amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan, as set forth below:
  evidence_url: https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.